 @article{Li_2019, title={Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer}, volume={11}, ISSN={1946-6242}, url={http://dx.doi.org/10.1126/scitranslmed.aax0428}, DOI={10.1126/scitranslmed.aax0428}, number={521}, journal={Science Translational Medicine}, publisher={American Association for the Advancement of Science (AAAS)}, author={Li, Yanjing and He, Yiping and Butler, William and Xu, Lingfan and Chang, Yan and Lei, Kefeng and Zhang, Hong and Zhou, Yinglu and Gao, Allen C. and Zhang, Qingfu and Taylor, Daniel G. and Cheng, Donghui and Farber-Katz, Suzette and Karam, Rachid and Landrith, Tyler and Li, Bing and Wu, Sitao and Hsuan, Vickie and Yang, Qing and Hu, Hailiang and Chen, Xufeng and Flowers, Melissa and McCall, Shannon J. and Lee, John K. and Smith, Bryan A. and Park, Jung Wook and Goldstein, Andrew S. and Witte, Owen N. and Wang, Qianben and Rettig, Matthew B. and Armstrong, Andrew J. and Cheng, Qing and Huang, Jiaoti}, year={2019}, month=dec }
